OpAns

OpAns is a private U.S.-based contract research organization and analytical laboratory focused on supporting drug discovery, preclinical, toxicology, and clinical studies. The company specializes in bioanalytical method development and validation, HPLC-MS/MS testing, separations chemistry, pediatric clinical trial support, and microsampling. A distinguishing asset is its patented amasse dried bio-fluid specimen collection device, which is used to enable quantitative dried blood or other bio-fluid sampling workflows. In addition to CRO services, OpAns offers clinical diagnostics and testing services spanning therapeutic drug monitoring, steroid hormone monitoring, toxicology, workplace testing, justice-system drug testing, and chemical confirmation. The business appears to be a services and platform company rather than a therapeutics developer, with revenue generated from analytical testing, laboratory services, and specimen collection technology.